Moderna Pauses mRNA RSV Vaccine Trial For Children

Health & LifestyleNewsPublisher's Picks
514

Listen to article (english)

Translate to Spanish or other 102 languages!

In recent clinical trials, two experimental RSV vaccines for babies may not only have failed to protect them, but actually made some of them sicker when they got RSV or another respiratory virus. Image for illustration purposes
In recent clinical trials, two experimental RSV vaccines for babies may not only have failed to protect them, but actually made some of them sicker when they got RSV or another respiratory virus. Image for illustration purposes

Mega Doctor News

- Advertisement -

By Jon Cohen / Science.org

Recently approved adult vaccines against respiratory syncytial virus (RSV) are already saving lives. But prospects have dimmed for some infant vaccines against the virus, which each year kills up to 100,000 children under age 5 around the world and is the leading cause of infant hospitalizations in the United States. In recent clinical trials, two experimental RSV vaccines for babies may not only have failed to protect them, but actually made some of them sicker when they got RSV or another respiratory virus. 

Follow the link below for the full story:

- Advertisement -

https://www.science.org/content/article/safety-signal-moderna-s-rsv-vaccine-studies-halts-trials-other-vaccines-childhood

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Stay-At-Home Mom Turns Her Life Around At STC 
Next article
Help Loved Ones Seek Support, Medical Help Early for Holiday Anxiety, Depression

More Articles

AACT NOW to Launch Rally the Vote Across Rio Grande Valley

The Advocacy Alliance Center of Texas, known as AACT NOW, will officially launch its Rally the Vote initiative Thursday, Oct. 1, bringing together community partners working to expand access to accurate, nonpartisan election information across the Rio Grande Valley.

STHS and Prominence Health Empower Seniors This World Heart Day

World Heart Day serves as a powerful reminder that cardiovascular disease remains one of the greatest threats to the health and well-being of older adults.

DHR Health Offers Mammogram Screening Special During “Breast Cancer Awareness Month”

October is “Breast Cancer Awareness Month,” and DHR Health is encouraging women to prioritize their breast health by offering their annual mammogram screening special.

FDA Approves First Treatment for MCT8 Deficiency

The U.S. Food and Drug Administration approved Emcitate (tiratricol) tablets for oral suspension to treat peripheral thyrotoxicosis (excess thyroid hormone levels in the blood that causes symptoms, such as rapid heart rate, increased blood pressure and adverse effects on metabolism) in patients with MCT8 deficiency, also known as Allan-Herndon-Dudley syndrome.
- Advertisement -